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Abstract. 
 
The neuronal microtubule-associated pro-
tein tau plays an important role in establishing cell po-
larity by stabilizing axonal microtubules that serve as 
tracks for motor-proteinÐdriven transport processes. 
To investigate the role of tau in intracellular transport, 
we studied the effects of tau expression in stably trans-
fected CHO cells and differentiated neuroblastoma 
N2a cells. Tau causes a change in cell shape, retards cell 
growth, and dramatically alters the distribution of vari-
ous organelles, known to be transported via microtu-
bule-dependent motor proteins. Mitochondria fail to be 
transported to peripheral cell compartments and clus-
ter in the vicinity of the microtubule-organizing center. 
The endoplasmic reticulum becomes less dense and no 
longer extends to the cell periphery. In differentiated 
N2a cells, the overexpression of tau leads to the disap-
pearance of mitochondria from the neurites. These ef-
fects are caused by tauÕs binding to microtubules and 
slowing down intracellular transport by preferential im-
pairment of plus-endÐdirected transport mediated by 
kinesin-like motor proteins. Since in AlzheimerÕs dis-
ease tau protein is elevated and mislocalized, these ob-
servations point to a possible cause for the gradual de-
generation of neurons.
Key words: mitochondria ¥ transport ¥ endoplasmic 
reticulum ¥ exocytosis ¥ AlzheimerÕs disease
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 microtubule network plays an important role in
maintaining cellular morphology, in mitotic pro-
cesses, in intracellular trafficking, and in establish-
ing cellular polarity and neurite outgrowth in differentiat-
ing neurons (Drubin and Nelson, 1996; Li and Black, 1996;
Goodson et al., 1997). Microtubules serve as tracks for the
movement of mitochondria (Nangaku et al., 1994; Morris
and Hollenbeck, 1995; Rickard and Kreis, 1996), lyso-
somes (Hollenbeck and Swanson, 1990), peroxisomes
(Wiemer et al., 1997) and various other organelles such as
endocytotic or exocytotic vesicles (Scales et al., 1997). Fur-
thermore, they are important in establishing and maintain-
ing the functionality of the endoplasmic reticulum (Water-
man-Storer et al., 1995). Microtubule (MT)
 
1
 
-dependent
transport is achieved through motor proteins such as
dynein or kinesin and their relatives (Waterman-Storer
and Salmon, 1997; Hirokawa, 1998; Lippincott-Schwartz,
1998). Kinesin is a plus-endÐdirected motor, whereas
dynein-related motor proteins move in the opposite di-
rection (Brady, 1995; Vallee and Sheetz, 1996). The or-
ganelles are linked to the motors via membrane/organelle-
bound adaptor proteins such as kinectin or dynactin
(Kumar et al., 1995; Burkhardt et al., 1997).
The microtubule tracks are stabilized by microtubule-
associated proteins (MAPs) such as MAP2, tau, MAP4,
and others. These are mostly filamentous proteins that
bind to the microtubule surface and promote microtubule
assembly (for reviews, see Hirokawa, 1994; Mandelkow
and Mandelkow, 1995). The developmental regulation of
MAPs, for instance in neuronal differentiation, suggests
an important role in organizing the microtubule cytoskele-
ton (Matus, 1994). Tau is enriched in axons, MAP2 in the
somatodendritic compartment of neurons (Binder et al.,
1985), whereas MAP4 can be found in many types of tis-
sues (Chapin and Bulinski, 1991; West et al., 1991). MAP2,
tau, and MAP4 share a remarkable sequence homology in
the conserved repeat regions located in the COOH-termi-
nal microtubule-binding domain (Chapin and Bulinski,
1992). The repeated motifs are preceded by an NH
 
2
 
-termi-
nal projection domain that has been suggested to serve as
a spacer between microtubules (Chen et al., 1992) or as an
anchor for cellular enzymes (Obar et al., 1989).
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hanced green fluorescent protein; MAP, microtubule-associated protein;
MT, microtubule; MTOC, microtubule organizing center; TMR, tetrame-
thylrhodamine.
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Since motor proteins and MAPs both interact with the
microtubule surface, the question arises whether MAPs in-
terfere with the movement of motor proteins. Several
studies have suggested that this is the case for certain
MAPs, especially those of higher molecular weight. Thus,
MAP2 can inhibit the motility of dynein or kinesin in vitro
(Paschal et al., 1989; Von Massow et al., 1989; Lopez and
Sheetz, 1993; Hagiwara et al., 1994), while smaller frag-
ments had only a weak effect. This could be accounted for
in several ways: (
 
a
 
) MAPs could have a general steric
blocking effect of the extended NH
 
2
 
-terminal projection
domain; (
 
b
 
) MAPs could compete with motors for com-
mon binding sites, probably on beta-tubulin (Hagiwara et
al., 1994); and (
 
c
 
) MAPs could affect transport processes
indirectly by altering microtubule dynamics (Waterman-
Storer and Salmon, 1997).
When MAP4 is overexpressed in mouse L
 
tk
 
2
 
 cells, it in-
terferes with motor-proteinÐdependent organelle motility
and trafficking in vivo (Bulinski et al., 1997). Furthermore,
overexpression of tau or MAP2c in COS-fibroblasts indi-
cates that both MAPs might function as phosphorylation-
dependent regulators of organelle transport (Sato-Harada
et al., 1996). The phosphorylation and dephosphorylation
of microtubule-associated proteins is believed to be a key
factor regulating the affinity to microtubules, thereby fa-
cilitating and supporting vital cellular processes such as
proliferation, differentiation, and trafficking through sta-
bilization of the tracks for motor proteins (Lopez and
Sheetz, 1995; Mandell and Banker, 1996; Sato-Harada et al.,
1996; Drewes et al., 1997). Indeed, MAPs isolated from
cells are phosphorylated and it is well documented that
this phosphorylation interferes with binding to microtu-
bules in vitro and in vivo (Drechsel et al., 1992; Biernat et al.,
1993; Illenberger et al., 1996).
In axonal growth, where a dynamic microtubule array is
indispensable for differentiation, the phosphorylation and
distribution of tau are correlated (Mandell and Banker,
1996; Li and Black, 1996), suggesting a regulated balance
between kinases and phosphatases, as well as a finely
tuned gradient of tau concentration. In AlzheimerÕs dis-
ease (AD), this balance between kinases and phosphatases
seems to be disturbed (Trojanowski and Lee, 1995; Man-
delkow et al., 1995). Neurofibrillary tangles, one of the
hallmarks of this disease, consist of paired helical fila-
ments, which are mainly composed of hyperphosphory-
lated microtubule-associated protein tau (Wischik et al.,
1988). Furthermore, tau in AD mislocalizes to the somato-
dendritic compartment of neurons (Braak et al., 1994) and
tau concentration has been reported to be elevated in AD
brain to a significant extent (Khatoon et al., 1992). This
further strengthens the importance of proper control of
posttranslational modifications, localization, and intracel-
lular concentration of microtubule-associated proteins in
vivo.
These observations lead us to investigate whether the
overexpression of tau protein had an effect on organelle
and vesicle trafficking in cultured cells. This approach had
been useful for studying the distribution of exogenous
MAPs (Barlow et al., 1994; Olson et al., 1995; Bulinski et
al., 1997; Kaech et al., 1996). In previous studies, we had
shown that CHO and neuroblastoma N2a cells can serve
as models for the state of MAP phosphorylation during
the cell cycle, and that the phosphorylation of tau by the
kinase MARK leads to microtubule breakdown (Preuss et
al., 1995; Drewes et al., 1997; Illenberger et al., 1998). Here
we demonstrate that the overexpression of tau leads to a
change in cell shape, loss of polarization, and the retarda-
tion of cell growth. One of the most visible consequences
is the dramatically altered distribution of mitochondria.
Instead of being dispersed throughout the cytoplasm, the
mitochondria become clustered near the nucleus at the mi-
crotubule organizing center (MTOC). In differentiated
neuroblastoma cells, the neurites become nearly devoid of
mitochondria. The endoplasmic reticulum becomes less
dense and retracts from the cell periphery or from neu-
rites. Transferrin endocytosed by clathrin-coated vesicles
accumulates near the MTOC and recycling is significantly
slowed down. These effects can be explained by assuming
that tau interferes with MT-driven transport, in the case of
mitochondria preferentially with the plus-endÐdirected
transport (by kinesin-like motors) so that the minus-endÐ
directed transport (by dynein) predominates. This results
in a net inward transport of mitochondria and other or-
ganelles such as peroxisomes towards the MTOC, where
the microtubule minus-ends are organized. The perturba-
tions of the balance in microtubule-dependent transport,
especially in neurites, would be consistent with the ob-
served impairment of axonal traffic in AlzheimerÕs disease
neurons, their loss of polarity, and their subsequent degen-
eration.
 
Materials and Methods
 
Cell Culture
 
CHO cells were grown in HAMÕs F12 medium supplemented with 10%
fetal calf serum and 2 mM glutamine (Biochrom, Berlin, Germany). For
immunofluorescence, cells were seeded onto coverslips at a density of 2 
 
3
 
10
 
4
 
 cells/cm
 
2
 
 in 24-well culture dishes and grown overnight at 37
 
8
 
C with
5% CO
 
2
 
. N2a neuroblastoma cells were grown in MEM Earle supple-
mented with 10% fetal calf serum, 2 mM glutamine (Biochrom) and 1%
nonessential amino acids (Sigma Chemical Co., Deisenhofen, Germany).
Differentiation of N2a cells was achieved by addition of 1 
 
m
 
M retinoic
acid (Sigma Chemical Co.) for 24Ð48 h in the presence of 0.1% fetal calf
serum. For stable transfection, plasmids derived from pcDNA3 (Invitro-
gen Corp., Leek, The Netherlands) coding for the longest human tau-
isoform htau40 under the control of the cytomegalovirus promoter were
introduced into the cells with the DOTAP-method (Boehringer Mann-
heim, Mannheim, Germany) according to the manufacturerÕs instructions.
Stable transfectants were selected in the presence of 800 
 
m
 
g/ml (CHO) or
1 mg/ml geneticin (N2a) as described (Preuss et al., 1995), and subse-
quently recloned.
 
Antibodies and Dyes
 
The following antibodies were used: rat monoclonal antitubulin antibod-
ies YL1/2 and mouse monoclonal antibody DM1A were purchased from
Serotec (Oxford, UK) and Sigma Chemical Co., respectively. Polyclonal
rabbit antiÐtau antibody K9JA was from DAKOPATTS (Hamburg, Ger-
many), polyclonal rabbit antibody used as an ER marker was a gift from
Dr. D. Louvard (Institut Curie, Paris; Louvard et al., 1982) and polyclonal
anticatalase antibody was from Dr. W. Just (University of Heidelberg,
Heidelberg, Germany). Antivimentin antibody V9 was from Boehringer
Mannheim. All fluorescently (TRITC, FITC, and AMCA) labeled sec-
ondary antibodies were from DIANOVA (Hamburg, Germany). Fluores-
cent dyes DiOC
 
6
 
(3), MitoTrackerª Green, MitoTrackerª Red, and
rhodamine-labeled transferrin were purchased from Molecular Probes,
Inc. (Eugene, OR). DiOC
 
6
 
(3) was used as a stain for in vivo observation
of the ER at 2.5
 
 m
 
g/ml. 
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Immunofluorescence
 
Cells were fixed with 2% paraformaldehyde or methanol, and incubation
with antibodies was performed essentially as described (Preuss et al.,
1995). Tau isoforms tightly bound to microtubules can be visualized by
methanol fixation (which allows unbound protein to diffuse out, see Fig.
2 
 
c
 
). By contrast, weakly bound constructs (e.g., K10, K12) cannot be visu-
alized by methanol fixation (since they would diffuse away). Instead, it is
necessary to use paraformaldehyde, which fixes all cellular proteins but
tends to dissociate tau from microtubules (see Fig. 3, for details see Illen-
berger et al., 1998). To visualize mitochondria, MitoTrackerª Green was
added at a concentration of 400 nM 30 min before fixation. CHO cells sta-
bly transfected with human tau40 or mock-transfected cells were incu-
bated for 1 h with 5 
 
m
 
M nocodazole (Sigma Chemical Co.) or 6 h with
1Ð10 
 
m
 
M taxotere (Rhone-Poulence Rorer, Vitry, France). Cells were
fixed before and 1 or 4 h after nocodazole, and 6 h after taxotere treat-
ment, respectively. Cells were examined with an Axioplan fluorescence
microscope (Carl Zeiss Jena GmbH, Jena, Germany) equipped with a
100
 
3
 
 oil-immersion objective and filters optimized for triple-label exper-
iments. Pictures were taken with a cooled CCD camera (Visicam; Visitron,
Puchheim, Germany) and analyzed using the MetaMorph
 
¨ 
 
software pack-
age (Visitron). The fraction of the cell area containing mitochondria was
quantified as follows: after fixation and immunofluorescence labeling, the
pictures were recorded and the areas containing mitochondria were circum-
scribed manually (omitting the nucleus) and calculated. The same was done
with the total cell area visible in the microtubule stain. A minimum of 30
cells were measured per experiment and the ratios plotted (e.g., see Fig. 11).
 
Microinjection
 
Microinjection experiments were performed as described (Preuss et al.,
1997). In brief, cells were seeded onto coverslips at a density of 2 
 
3 
 
10
 
4
 
cells in 35-mm dishes and incubated overnight. Recombinant protein, pre-
pared as described (Biernat et al., 1993; Gustke et al., 1994) was concen-
trated in Microcon microconcentrators (Amicon Inc., Beverly, MA) ac-
cording to the manufacturerÕs instructions. During this procedure, the
buffer was changed to 25 mM HEPES, pH 7.2, 1 mM PMSF, and protein
was then microinjected with an Eppendorf Micromanipulator 5171 at con-
stant pressure within 15 min. MitoTrackerª Red was added 30 min be-
fore fixation at a concentration of 200 nM, and cells were finally fixed with
paraformaldehyde at given time points and prepared for immunofluores-
cence. For quantitative analysis of the intracellular concentration of tau
protein in the tau40-stable cell line, 1.9, 0.95, and 0.38 mg/ml purified re-
combinant tau protein, as well as buffer only, were microinjected into
CHO cells. Cells were then fixed in parallel with the tau-stable cell line
and stained with a polyclonal antiÐtau antibody. The fluorescence of the
tau stain was then quantified using the CCD camera and the MetaMorph
 
¨
 
software package and normalized to the cell dimensions. A minimum of
80 cells were analyzed per microinjection and at least 100 tau-stable cells
were scored. Regression analysis of the normalized fluorescence intensi-
ties of microinjected cells was performed with the program Sigma Plot
(
 
R
 
 
 
5 
 
0.9995), and the mean intracellular tau concentration of the stable
cell line was calculated.
 
Monitoring Mitochondrial Distribution and 
Endoplasmic Reticulum In Vivo
 
For the visualization of mitochondria in vivo, cells were seeded onto
LabTek chambered cover glass (NUNC, Inc., Naperville IL.) at 70% con-
fluency. 30 min before immunofluorescence examination, MitoTrackerª
Green or Red was added to cells at a final concentration of 200 nM, cells
were then rinsed once with medium. For monitoring mitochondrial redis-
tribution tau-stable CHO cells were incubated for 1 h with 5 
 
m
 
M nocoda-
zole and 200 nM MitoTrackerª Green. Disassembly of the microtubule
network was confirmed by fixation and tubulin staining in immunofluores-
cence microscopy. Nocodazole was then removed and cells were exam-
ined with the cooled CCD camera on an inverted microscope (Axiovert
10; Carl Zeiss Jena GmbH) using standard filters for FITC fluorescence.
Staining of the endoplasmic reticulum was achieved with DiOC
 
6
 
(3) at a
concentration of 2.5 
 
m
 
g/ml, 30-min incubation at 37
 
8
 
C, and rinsing cells
once with medium. Immunofluorescence microscopy was then performed
as described above.
 
Transferrin Uptake and Recycling
 
Cells were grown in 35-mm six-well tissue culture plates for 2 d to 
 
z
 
80%
confluency at 37
 
8
 
C and 5% CO
 
2
 
. Supernatant was then replaced by se-
rum-free medium, and 2 h later tetramethylrhodamine (TMR)-labeled
transferrin was added to a final concentration of 380 nM. Cells were fur-
ther incubated for 1 h to achieve maximal transferrin uptake. Medium
containing excess or recycled transferrin was removed and new medium
containing 60 
 
m
 
g/ml partially Fe
 
2
 
1
 
-saturated transferrin (Sigma Chemical
Co.) was added. Recycling was then monitored by again removing me-
dium at given time points and quantitating fluorescence of TMR-labeled
transferrin in a Fluoro Max spectrofluorometer (Spex Industries Inc., Edi-
son, NJ) at 575 nm emission and 552 nm excitation wavelength. Cells were
then trypsinized, lysed, and protein concentration was determined to nor-
malize fluorescent signals to total protein present in the culture dishes,
representing cell density. At least five independent experiments were per-
formed with tau-stable and mock-transfected CHO cells to ensure statisti-
cal significance. To quantitate residual intracellular transferrin, cells were
seeded onto coverslips, grown overnight, and subsequently saturated with
TMR transferrin (see above). Cells were then fixed in methanol either im-
mediately or 7 min after removal of TMR transferrin. Residual transferrin
fluorescence was quantitated as above using standard filters for rho-
damine fluorescence. Pictures were corrected by background subtraction
and shadowing correction provided with the MetaMorph
 
¨ 
 
software pack-
age (Visitron). At least 300 different cells per time point and cell line were
quantified by thresholding.
 
Tau Isoforms and Constructs
 
Human brains contain mainly six isoforms of tau generated by alternative
splicing (Goedert et al., 1989). The present work focuses on the largest
(tau40, 441 residues) and smallest (tau23, 352 residues) isoform, contain-
ing four or three repeats in their microtubule-binding region (Fig. 1). Clon-
ing, bacterial expression, and purification was done as described (Biernat
et al., 1993; Gustke et al., 1994). Other tau constructs were also generated
as described, such as K12 and K10 (derived from htau23, three repeats
with the COOH-terminal flanking region or the whole COOH-terminal
tail), K35 (which comprises the microtubule-binding domain of tau, in-
cluding the proline-rich region upstream of the repeats), and K23 (a vari-
Figure 1. Domain structure of tau isoforms and constructs. Tau40
is the longest tau isoform in the human CNS, occurring mostly in
axons (Goedert et al., 1989). It consists of 441 amino acid resi-
dues and can be divided into an NH2-terminal projection domain
and a COOH-terminal microtubule binding domain containing
four imperfect repeats (R1ÐR4) and basic proline-rich sequences
on either side that act as microtubule targeting domains (shaded
dark, P1, and P2). The repeats show high homology between tau,
MAP2, and MAP4. The shaded NH2-terminal inserts and repeat
two can be alternatively spliced, resulting in six different tau iso-
forms. The predominantly embryonic isoform tau23 lacks all
three inserts (352 residues). Tau constructs K12 and K10 are de-
rived from tau23, they contain three repeats plus either a COOH-
terminal flanking region (K12) or the whole COOH-terminal tail
(K10). K35 contains three repeats and the basic proline-rich re-
gions on either side, including the COOH-terminal tail. K23 con-
tains all of tau23 except the repeats. 
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ant of tau23 lacking the three repeats). The dissociation constants of these
constructs and their binding to cellular microtubules were reported previ-
ously (Gustke et al., 1994; Preuss et al., 1997): tau40 (
 
K
 
d
 
 5 
 
1.1 
 
m
 
M), tau23
(2.5 
 
m
 
M), K35 (1.0 
 
m
 
M), K23 (6.5 
 
m
 
M), K10 (18.5 
 
m
 
M), and K12 (7.1 
 
m
 
M).
 
Inhibition of Dynein-dependent Transport by 
Overexpression of Dynamitin
 
Dynamitin (p50) expression plasmid was transfected into tau-stable CHO
cells with the DOTAP-method. 6 h after transfection, cells were fixed in
paraformaldehyde as described (see above). Mitochondria were stained
with MitoTrackerª Red (Molecular Probes, Inc.), tubulin with rat mono-
clonal antitubulin antibody (YL1/2; Serotec) and transfected p50-dyna-
mitin with mouse monoclonal antidynamitin 50-I. Immunofluorescence
analysis was performed as described above. The p50 expression plasmid
and antibody were generous gifts from C. Echeverri and R. Vallee
(Worcester Foundation, Shrewsbury, MA) (Burkhardt et al., 1997).
 
Monitoring Transport of Individual Mitochondria After 
Nocodazole Removal 
 
Cells were seeded onto LabTek chambered cover glass (NUNC, Inc.) at
70% confluency. Nocodazole was then added at a final concentration of
1 
 
m
 
M for 2 h and subsequently removed. 30 min before removal, Mi-
toTrackerª Red was added at a concentration of 200 nM to visualize mi-
tochondria. After an additional 30 min to allow recovery of the microtu-
bule cytoskeleton, reaggregation of the organelles was monitored in vivo
on an inverted microscope with a cooled CCD camera (see above) by re-
cording pictures every second for 2 min with the following constraint: only
mitochondria translocated with a minimum distance of 1 
 
m
 
m and a veloc-
ity of 0.5 
 
m
 
m/s were taken into consideration to exclude diffusional pro-
cesses. By using the nucleus as a reference, transported mitochondria
were grouped into three categories: movement towards the nucleus (cen-
tripetal; denoted as 
 
2 
 
in Fig. 7) was regarded as minus-end directed,
movement towards the cell periphery (centrifugal; denoted as 
 
1
 
) as plus-
end directed and all other movements as circumferential (denoted as 
 
2
 
/
 
1
 
).
 
Results
 
Cell Shape and Mitochondrial Distribution Is Strongly 
Altered in Tau-overexpressing CHO Cells
 
To investigate the effects of human tau expression in vivo,
we established CHO cells stably transfected with tau40, an
isoform containing four repeats (Preuss et al., 1995, and
this report). Immunofluorescent staining of microtubules
showed that their network was normal and contained
bound tau (Fig. 2), consistent with similar results on
MAP4-transfected cells (Olson et al., 1995; Nguyen et al.,
1997). In particular, no bundling of microtubules was seen,
contrary to experiments with transient transfection (Kanai
et al., 1989; Lee and Rook, 1992) or with microinjection
(Preuss et al., 1997), where higher cellular concentrations
of MAPs are obtained. To calibrate the intracellular tau
concentration, we microinjected different amounts of puri-
fied, recombinant tau protein into CHO cells, and pre-
pared them for immunofluorescence analysis in parallel
with the tau-stable cells (see Materials and Methods). This
yielded an average concentration of 0.04 
 
m
 
g/ml tau in the
stably transfected cells, corresponding to 
 
z
 
1 
 
m
 
M. Since
the cellular tubulin concentration is 
 
z
 
40 
 
m
 
M (Hiller and
Weber, 1978), the ratio of tau to tubulin remained low,
 
z
 
1:40, similar to that reported for PC12 (Drubin et al.,
1985) or HeLa cells (Bulinsky and Borisy, 1979). Further-
more, stable expression of tau in PC12 cells under control
of the cytomegalovirus promoter (which was used in our
experiments) resulted in only a twofold increase of intra-
cellular tau-protein level (Brandt et al., 1995). Taken to-
gether, these data show that the concentration of tau in the
stably transfected CHO and N2a cells is in the range of en-
dogenous MAP levels in the control cells and increases the
amount of total MAP only about two- to threefold.
In spite of the low cellular concentration, the expression
of tau leads to conspicuous changes in cell shape and
growth behavior. Whereas control cells were elongated,
tau-transfected CHO cells rounded up (compare Fig. 2, 
 
b
 
vs. 
 
e
 
). This phenotype can be evoked in several ways, but
one possibility is the inhibition of the motor protein kine-
sin as described by Rodionov et al. (1993), and a similar in-
terpretation is appropriate in our case as well (see below).
A second noticeable effect was that overexpression of tau
in CHO cells slowed down proliferation approximately
twofold (data not shown), similar to observations with
MAP4-transfected cells (Nguyen at al., 1997).
We wanted to investigate whether the observed changes
in shape and proliferation were indeed related to microtu-
bule-dependent transport and therefore analyzed the cells
with several markers for organelles. This revealed a re-
markable clustering of mitochondria in tau40-expressing
CHO cells near the nucleus in the vicinity of the microtu-
bule organizing center (Fig. 2, 
 
a
 
 and
 
 c
 
). This effect was re-
produced in two independently generated tau40-stable cell
lines, thus ruling out recloning artifacts. In contrast, mock-
transfected CHO cells showed that mitochondria were
dispersed throughout the entire cytoplasm (Fig. 2 
 
d
 
), fre-
quently aligned with microtubules, suggesting a micro-
tubule-dependent organization of mitochondria. The frac-
tion of the cell area containing mitochondria decreased
from 66.1% in mock-transfected cells to 27.7% in the tau-
stable cell line (see Fig. 10). To exclude the possibility of a
fixation artifact, we established CHO cells stably trans-
fected with an enhanced green fluorescent protein
(EGFP)Ðtau fusion protein that allowed us to monitor
tauÕs effect on mitochondrial distribution in living cells.
EGFP tau was tightly associated with microtubules (as
seen by EGFP fluorescence) and led to the same effects on
mitochondrial clustering (data not shown).
Since there are several reports (e.g., Summerhayes et al.,
1983) linking the distribution of mitochondria to the integ-
rity of the intermediate filament system, we investigated
whether the vimentin network was altered through tau
overexpression. In tau40-stable cells, the extension of this
filamentous network is significantly reduced and becomes
located in a perinuclear area (Trinczek, B., A. Ebneth,
E.-M. Mandelkow, and E. Mandelkow, manuscript in prep-
aration). Thus, one might speculate that tauÕs effects on
the intermediate filament system may account for the ag-
gregation of mitochondria at the MTOC. However, when
treating cells with nocodazole to disrupt microtubules, mi-
tochondria began to disperse again (see below), whereas
the extension of the intermediate filament network was
not altered in the tau-stable CHO cells despite disruption
of microtubules. It has been shown that the disruption of
microtubules leads to a collapse of the intermediate fila-
ment system (Klymkowski et al., 1989). Removal of no-
codazole again did not affect the extension of the vimentin
network (data not shown), but led to a reclustering of mi-
tochondria, which indicates that the integrity of the micro-
tubule system, not the intermediate filament system, is re-
sponsible for the observed phenotype of mitochondrial
clustering in tau40-stable cells. 
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Interestingly, inhibition of kinesin motors by microinjec-
tion of an inhibitory antibody into fibroblasts led to a
strikingly similar phenotype of a perinuclear localization
of the vimentin system (Gyoeva and Gelfand, 1991).
Mitochondria are organelles that can disappear from
cellular regions with lowered metabolic demand (e.g.,
Morris and Hollenbeck, 1993). This raises the possibility
that clustering of mitochondria was not due to an impair-
ment of the cellÕs transport, but to a change in the meta-
bolic activity in the periphery due to the overexpression of
tau. For this reason, we looked for other organelles known
to be transported via microtubule-dependent motors and
asked if they were clustered, too. This was indeed the case.
When staining tau-stable cells with an antibody raised
against catalase, an enzyme present in the matrix of perox-
isomes, the organelles were significantly enriched in the
perinuclear region, whereas in control cells they were
evenly distributed (data not shown). This argues that or-
ganelle clustering near the MTOC is caused by a general
influence of tau on microtubule-dependent plus-endÐ
directed transport, rather than a selective retraction of mi-
tochondria in response to altered metabolic demands.
To identify the domains of tau responsible for the clus-
tering of mitochondria, we studied CHO cells stably trans-
fected with several tau isoforms or constructs whose be-
havior had already been characterized in vitro (Gustke et al.,
1994; Fig. 1): human tau40 (the longest isoform in the cen-
tral nervous system), tau23 (the shortest isoform, found
predominantly in embryonic brain), K12 (a tau construct
containing only the three repeats plus the COOH-terminal
flanking region), K10 (containing three repeats plus the
whole COOH-terminal rest of the molecule), K35 (con-
taining three repeats and both flanking regions), and K23
(a variant of tau23 without the repeats). The isoforms
Figure 2. Mitochondria accumulate near the
MTOC in CHO cells overexpressing tau. Cells
stably transfected with tau40 (aÐc) and mock-
transfected CHO cells (dÐf). Microtubules were
stained with antibody DM1A (b and e) and tau
with polyclonal antiÐtau antibody K9JA (c and
f). Mitochondria were visualized with Mito-
Trackerª Green (a and d). Cells were fixed
in methanol 30 min after addition of Mito-
Trackerª Green. In tau-stable cells (aÐc), there
is a striking clustering of mitochondria near the
MTOC (seen near the nucleus where the micro-
tubule stain is most intense), whereas in mock-
transfected cells (dÐf) the mitochondria are dis-
persed throughout the cytoplasm. In addition,
the tau-stable cells are more rounded up com-
pared with control cells. Bar, 20 mm. 
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tau40, tau23, and K35 induced pronounced mitochondrial
clustering around the MTOC (Figs. 2 and 3, 
 
aÐd
 
, and data
not shown), whereas K10 (data not shown), K12, and K23
did not show the effect (Fig. 3, 
 
eÐh
 
). This correlates well
with the strengths of binding (dissociation constants 
 
z
 
1Ð2
 
m
 
M for tau40, tau23, and K35, compared with 
 
z
 
7Ð20 
 
m
 
M
Figure 3. Effects of different tau constructs on mitochondrial dis-
tribution in CHO cells. Mitochondrial distribution in CHO cells
stably transfected with different tau constructs was examined af-
ter paraformaldehyde fixation. This allows the visualization of to-
tal tau in the cells, but tends to dissociate tau from the microtu-
bules (see Materials and Methods). Human tau23, the shortest
tau-isoform (a and b), as well as K35 (c and d), a tau construct
lacking nearly the entire projection domain (see Fig. 1) both led
to the phenotype of mitochondrial clustering near the MTOC as
seen in tau40-stable cells. On the other hand, K23 (e and f), a tau
construct lacking the microtubule-binding region and K12 (g and
h), consisting mainly of this MT-binding region (Fig. 1), did not
alter the distribution of mitochondria. This argues for a tight
binding of tau to microtubules as a prerequisite for impairment of
plus-endÐdirected transport of these organelles and excludes the
possibility that tau might inhibit kinesin by directly interacting
with the motor protein. Mitochondria were stained with Mi-
toTrackerª Red (a, c, e, and g) and transfected tau with poly-
clonal antiÐtau antibody K9JA (b, d, f, and h). Bar, 20 mm.
Figure 4. Microinjection of recombinant tau protein leads to mi-
tochondrial clustering near the MTOC. Wild-type CHO cells were
microinjected with 1.3 mg/ml (z1.2 mM) of purified recombinant
tau protein and incubated for 4 h. After addition of Mi-
toTrackerª Red (a and b), cells were fixed with paraformalde-
hyde and stained with antibodies against tubulin (c and d) and
tau (e and f). Mitochondrial clustering is visible even within 4 h
after microinjection. Note that the microtubule network retains
its normal appearance and that mitochondria in microinjected
cells similar as in the tau-stable CHO and N2a cells tend to clus-
ter at one side of the nucleus in the vicinity of the MTOC. The
cell periphery of microinjected cells is outlined for clarity. Bar,
10 mm.Ebneth et al. Tau Inhibits Kinesin-dependent Vesicle Trafficking 783
for the other constructs; Gustke et al., 1994). K35 binds
tightly but lacks parts of the NH2-terminal projection do-
main so that this domain appears to be of lesser impor-
tance for mitochondrial transport. Conversely, K10 and
K12 contain the repeats but lack the NH2-terminal projec-
tion and flanking domains. Thus, their binding to microtu-
bules is weak and this explains why they have no effect on
mitochondrial distribution. K23 is a special case because it
contains the projection domain, the two flanking domains,
but not the repeats. It binds to microtubules with reason-
able affinity (Kd z7 mM), but still does not influence mi-
crotubule-based traffic. These observations argue that a
high affinity of tau to microtubules is the major determi-
nant for observing the effects of tau overexpression and
that it is highly unlikely that tau inhibits plus-endÐdirected
transport by directly binding to kinesins.
Microinjection of Tau into CHO Cells Leads to 
Mitochondrial Clustering at the MTOC 
Next we asked whether the elevation of tau protein was di-
rectly responsible for the phenotype of mitochondrial clus-
tering at the MTOC, or whether it was due to other factors
not related to the protein level. Recombinant tau40 was
microinjected into mock-transfected CHO cells to a final
concentration of z1.2 mM where the microtubule network
is not affected (Preuss et al., 1997). Nevertheless, mito-
chondria began to accumulate near the nucleus within 4 h
(Fig. 4). Microinjection of mouse serum at the same con-
centration as a control on the other hand had no effect on
mitochondrial distribution (data not shown). Thus, the
phenotype can be generated without affecting the micro-
tubule cytoskeleton, suggesting that tau protein has a di-
rect effect on the redistribution of mitochondria, presum-
ably by retarding their plus-end directed movement (see
below).
Nocodazole and Taxotere Reverse the Effect of Tau on 
Mitochondrial Distribution 
To investigate whether the organization and integrity of
microtubules was important for the clustering of mito-
chondria, we applied two microtubule drugs, nocodazole
and taxotere. Nocodazole causes the disassembly of micro-
tubules, taxotere (a taxol derivative) causes their assembly
and stabilization (Jordan and Wilson, 1998). In the pres-
ence of taxotere, new microtubules are nucleated ran-
domly in the cytoplasm, independently of the MTOC, so
Figure 5. Disruption of microtubules by no-
codazole leads to a random distribution of
mitochondria in tau-stable CHO cells. Tau-
stable cells (a and b) and mock-transfected
CHO cells (c and d). Cells were treated with
nocodazole to disrupt the MT cytoskeleton,
fixed with methanol, and immunolabeled
with antibodies against tubulin (b and d).
In both cell lines, mitochondria, visualized
by addition of MitoTrackerª Green before
fixation (a and c), are now visible through-
out the entire cytoplasm even in the cell pe-
riphery, suggesting the existence of an intact
MT network as a prerequisite for mitochon-
drial clustering. Bar, 20 mm.The Journal of Cell Biology, Volume 143, 1998 784
that the defined polarity and orientation is lost (McNiven
and Porter, 1986; Weisshaar et al., 1992). If microtubules
mediated the relocalization of mitochondria towards the
cell center, one would expect that disruption of the micro-
tubule network in the tau-overexpressing cells might lead
to a wild-type distribution. This was indeed observed. Fig.
5 shows the disruption of microtubules in tau-stable CHO
cells treated with nocodazole, which resulted in an in-
creased cytosolic background staining arising from disas-
sembled tubulin dimers. Within 1 h after nocodazole treat-
ment, the mitochondria were redistributed to peripheral
regions of the cell. The mitochondria-containing area
thereby increases from 27.7 to 63.9%, which reaches the
value of control cells within the error margin (see Fig. 10).
Conversely, when nocodazole was removed again, an ap-
parently normal microtubule network reappeared within
about 15 min (data not shown), originating at the MTOC,
and the phenotype of mitochondrial clustering, clearly vis-
ible already within z1 h, was fully restored after z4 h, in-
dicating that the organelles were actively transported to-
wards the MTOC (see Figs. 6 and 10). Taken together,
these data suggest that a shift in the balance between plus-
and minus-endÐdirected motor activities through tau-
overexpression is responsible for the phenotypic effects.
Thus, the ratio of mitochondria actively transported to-
wards the cell periphery (that is plus-end directed) or to-
wards the cell center (the MTOC, minus-end directed) in
tau-stable versus control cells is expected to be altered by
tau overexpression. To investigate this in further detail,
cells were treated with nocodazole to achieve an even dis-
tribution of mitochondria in both cell lines. The microtu-
bule array was then allowed to recover by washing out the
drug and the direction of the movement of individual mi-
tochondria was analyzed. Although transport in general is
affected by tau overexpression (Fig. 7), irrespective of the
kind of motor activity, plus-endÐdirected transport de-
creased z10-fold, whereas minus-endÐdirected transport
dropped only about twofold, resulting in a net inward
transport of mitochondria in tau-stable cells compared
with control cells.
These results demonstrate that microtubule-dependent
processes are responsible for the clustering of mitochon-
dria. It also means that mitochondria can become dis-
persed independently of microtubules, presumably by dif-
fusion (in contrast to the ER, see below). The fact that
reconstitution of the MT network leads to a reclustering of
mitochondria near the cell center suggests that the overex-
pression of tau impairs predominantly the plus-endÐ
directed transport of these organelles (see below). If this
were true, one would expect that the normal distribution
of mitochondria could be restored even in tau-overex-
pressing cells by abolishing the polar organization of mi-
crotubules. This can be achieved by treatment of cells with
taxotere (at final concentrations of up to 10 mM), which
leads to microtubule nucleation with random orientations
throughout the cytoplasm. Fig. 8 shows that taxotere-
Figure 6. Reassembly of
microtubules after removal
of nocodazole restores the
clustering of mitochondria.
The microtubule cytoskele-
ton of tau-transfected CHO
cells was disrupted by addi-
tion of 5 mM nocodazole for
2 h. Pictures of living cells
were then taken after re-
moval of nocodazole and
reassembly of microtubules
at the indicated time
points. Mitochondria were
stained with MitoTrackerª
Green. Note that, concomi-
tant with microtubule reassembly, the phenotype of mitochondrial clustering at the MTOC near the nucleus begins to reappear
after z1 h. The cell periphery is outlined for clarity. Bar, 10 mm.
Figure 7. The ratio between
plus- and minus-endÐdirected
transport of mitochondria is
altered by tau overexpres-
sion. Tau-stable and control
cells were treated with no-
codazole to disrupt the mi-
crotubule cytoskeleton and
to achieve an even distribu-
tion of mitochondria in both
cell lines. The drug was
washed out after 2 h of incu-
bation and mitochondria
were stained with MitoTrackerª Red. Translocations of the or-
ganelles were then recorded for 2 min with a time interval of 1 s.
The direction of movement was regarded as plus-end directed
when the organelles were transported to the periphery (1), mi-
nus-end directed when transport was towards the nucleus (2),
and neutral (2/1) when movement was vertical to the axis be-
tween nucleus and periphery of the cells. Note that the relative
number of transported mitochondria is significantly lower for all
three groups in the tau-stable cell line (P , 0.0001, two tailed
StudentÕs t test). However, in tau-stable cells, the plus-endÐ
directed movement is significantly more affected (z10-fold)
than the reverse direction (2-fold). This leads to the phenotype
of mitochondrial clustering. At least 40 cells were analyzed for
quantitation, the total number of mitochondria ranged be-
tween 100 and 700 in both cell lines.Ebneth et al. Tau Inhibits Kinesin-dependent Vesicle Trafficking 785
treatment has a similar effect as nocodazole in restoring
the dispersed distribution of mitochondria. Again, the
mitochondria-containing area within the tau-stable cells
increases to 58.1%, comparable with the 66.1% of mock-
transfected cells (see Fig. 10). This result seems counterin-
tuitive since the two drugs have opposite effects on micro-
tubules, but it becomes understandable by considering
that taxotere randomizes microtubules (at the micromolar
concentrations used here), and thus destroys the basis for
directed transport. In other words, a phenotype caused by
impairment of plus-endÐdirected transport can manifest it-
self only in the presence of a polarized microtubule net-
work where microtubule minus ends converge on the
MTOC. Randomizing microtubule polarity by addition of
taxotere allows transport of mitochondria to the cell pe-
riphery by minus-endÐdirected motors and thus leads to a
redispersion of these organelles.
Inhibition of Dynein by Overexpression of
p50-Dynamitin Reverses the Effect of Mitochondrial 
Clustering by Tau
The minus-endÐdirected transport of mitochondria is thought
to depend on dynein (Hirokawa et al., 1990; Vallee et al.,
1995), and therefore one would expect that inhibition of
dynein would counteract the clustering of mitochondria
induced by overexpression of tau. We inhibited dynein by
transient transfection of the tau-overexpressing cells with
dynamitin, a subunit of the dynactin complex that is cru-
cial for the attachment between organelles and microtu-
bules (Burkhardt et al., 1997). Overexpression of dyna-
mitin in tau-stable cells significantly reduced the clustering
of mitochondria, whereas EGFP transfection as a control
had no effect on the mitochondrial distribution (Fig. 9).
The area containing mitochondria within the cells after
transfection increased from z28% in EGFP-transfected
tau-stable cells to 47.9% in dynamitin-overexpressing cells
(P , 0.0001, two-tailed StudentÕs t test; Fig. 10). The fact
Figure 8. Randomization of microtubule polarity by taxotere al-
lows clustered mitochondria to disperse again. Tau-stable cells
were treated with 10 mM taxotere for 6 h, which leads to an al-
tered microtubule organization. Note that the MTOC in taxo-
tere-treated cells is barely visible in the tubulin stain (b), in con-
trast to nontreated cells (compare Fig. 2). Microtubules are
nucleated randomly throughout the cytoplasm, thus abolishing
the role of the MTOC as an organizing element and therefore
abolishing the polarity of microtubules. Minus-endÐdirected mo-
tors are now able to transport mitochondria back to peripheral
regions in the tau-stable cells. Cells were fixed in methanol and
mitochondria were stained with MitoTrackerª Green (a), tubu-
lin was immunostained with DM1A (b). Bar, 10 mm.
Figure 9. Dynamitin overex-
pression restores the wild-
type distribution of mito-
chondria. Tau-stable cells
were transfected with dyna-
mitin (p50), a subunit of the
dynactin complex. 6 h after
transfection, the mitochon-
dria began to disperse again,
visualized with MitoTrackerª
Red after paraformaldehyde
fixation (a). Note that the
cell transfected with tau
and  dynamitin (arrow-
heads) shows dispersed mi-
tochondria, whereas the
neighboring tau-stable cells
show the typical clustering
near the MTOC. Dynamitin
was stained with antidyna-
mitin 50-1 antibody (b) and
tubulin with YL1/2 anti-
body (c). Bar, 20 mm.The Journal of Cell Biology, Volume 143, 1998 786
that mitochondria were not completely redispersed (in
contrast to the nocodazole-treated cells, where dispersal is
complete) is probably due to fixation of cells 6 h after
transfection. Since the overexpression of dynamitin af-
fects the organization of the MTOC (Burkhardt et al.,
1997), which in turn interferes with directed microtubule-
dependent transport of mitochondria, we analyzed only
those cells whose microtubule network was clearly unaf-
fected. However, the experiment demonstrates that dy-
nein motors are actively involved in the mitochondrial
transport and argues against different types of mecha-
nisms that operate in other situations (e.g., tethering to
shrinking microtubules; Lombillo et al., 1995).
Shape and Extension of the Endoplasmic Reticulum Is 
Altered by the Overexpression of Tau
Thus far, we concentrated on the microtubule-dependent
transport of mitochondria in transfected CHO cells. How-
ever, microtubules are responsible for transporting other
vesicles and organelles as well, notably the endoplasmic
reticulum (Terasaki and Reese, 1994). Its distribution ap-
pears to depend both on kinesin-dependent transport and
on an intact microtubule network (Vale and Hotani, 1988;
Hamm-Alvarez et al., 1993; Feiguin et al., 1994). To inves-
tigate if overexpression of tau would affect the ER, we
stained living cells with DiOC6(3), a fluorescent marker
for the ER. Overexpression of tau caused pronounced
changes in shape and extension of the ER (Fig. 11). First,
in tau-stable cells, the extension of the ER was strongly re-
duced so that it no longer reached the cell periphery. Sec-
ondly, the density and branching of the ER was signifi-
cantly decreased. As in the case of mitochondria, this
result is consistent with the assumption that plus-endÐ
directed transport along microtubules is perturbed.
On the other hand, observations with the microtubule
drugs taxotere and nocodazole showed that the behavior
of the ER is more complex. Taxotere partially restored the
wild-type distribution, although the ER did not fully reach
the cell periphery (data not shown). In contrast, after dis-
ruption of microtubules with nocodazole, the ER did not
expand again. These results confirm that organized micro-
tubules are necessary for the general constitution of the
ER, in addition to kinesin (Lippincott-Schwartz, 1998).
Recycling of Transferrin in Tau-overexpressing CHO 
Cells Is Slowed Down
Endo- and exocytotic processes depend on an intact mi-
crotubule cytoskeleton. We therefore asked whether the
overexpression of tau influences these processes as well,
using rhodamine-labeled transferrin as a marker. Trans-
ferrin is endocytosed via transferrin receptors and clath-
rin-coated vesicles and is actively transported along micro-
tubules by motor proteins through early and sorting
endosomes to recycling compartments in the pericentri-
olar region of the cell. It is finally released by exocytosis,
again via microtubule-dependent transport processes (Mar-
tys et al., 1995). The efflux of transferrin was measured by
removal of the supernatant at different time points and by
quantitating the exocytosed transferrin by fluorescence
(Fig. 12 a). At early time points (a few minutes after re-
moval of excess transferrin) the tau-stable cell lines
showed a significantly lower level of exocytosed transfer-
rin than the control cells, but this difference disappeared
later on (z20 min). Thus, the outward flow of exocytic
vesicles was retarded but not interrupted.
This observation was confirmed by quantitating the im-
munofluorescence of residual TRITC-labeled transferrin
in methanol-fixed tau-stable cells and mock-transfected
controls. Methanol-fixed tau-stable cells yielded a signifi-
cantly higher amount of transferrin 7 min after removal of
transferrin-containing media compared with mock-trans-
fected cells (Fig. 12 a; P , 0.0001, two-tailed StudentÕs t
test), mostly in the vicinity of the MTOC (the region of the
recycling compartment; Martys et al., 1995). Whereas
z50% of the initial intracellular transferrin had been exo-
cytosed in mock-transfected cells, only 10% had been re-
cycled in tau-stable cells during the same time period. This
correlates well with the experiment shown in Fig. 12 b,
where, conversely, the exocytosed transferrin was quanti-
tated. Again, after z7 min, only 50% of transferrin was
exocytosed in tau-stable cells compared with control cells.
Transport of Mitochondria and Endoplasmic
Reticulum into the Neurites of Differentiated
N2a-Neuroblastoma Cells Is Impaired by 
Overexpression of Tau 
In the experiments described so far, we focussed on CHO
cells to investigate tauÕs effects on transport processes.
The chief reasons were that CHO cells are well suited for
studying transport due to their flattened cell form and
their size, which facilitates observation and microinjec-
tion. Secondly, CHO cells do not normally express tau so
that the discrimination between endogenous MAPs (e.g.,
MAP4) and stably introduced tau is much easier than in
neuroblastoma cells. On the other hand, tau is expressed
mainly in neuronal tissue, raising the question whether the
effects of tau overexpression manifest themselves in neu-
ronal cells as well. For this reason, we stably transfected
Figure 10. Quantitation of
mitochondrial clustering af-
ter overexpression of tau,
drug treatment, and inhibi-
tion of dynein. The distribu-
tion of mitochondria was
quantified as described in
Materials and Methods. A
minimum of 30 cells were an-
alyzed per experiment (n). In
mock-transfected cells, mito-
chondria occupy up to 65%
of the total cell area. The
same is true in cells stably transfected with K23, a tau construct
lacking the microtubule-binding repeats (CHO-K23). This value
drops to z30% in tau40-stable cells (CHO-tau). Treatment of the
stably transfected cells with either nocodazole or taxotere re-
stores the wild-type distribution of mitochondria (CHO-tau no-
codazole or CHO-tau taxotere, respectively). The same effect can
be seen after transfection with dynamitin (CHO-tau transfection
dynamitin), but not after transfection of EGFP as a control pro-
tein (CHO-tau transfection EGFP; P , 0.0001, two-tailed Stu-
dentÕs t test). Removal of nocodazole again leads to clustering of
mitochondria at the nucleus (CHO-tau noc. removal; 4 h).Ebneth et al. Tau Inhibits Kinesin-dependent Vesicle Trafficking 787
human tau40 into the mouse neuroblastoma cell line N2a.
Although the cell body of N2a cells is very compact and
small (z10Ð20 mm, compared with z40 mm for CHO cells)
so that it is difficult to detect differences in mitochondrial
localization, the organelles appear to be clustered in the
vicinity of the nucleus in tau-stable compared with control
cells. Transport processes in the neurites of differentiated
N2a cells on the other hand can be monitored much more
easily because transport deficits in these structures accu-
mulate to a more significant extent. As shown by several
reports, tau protein is important for the generation of neu-
rites, and transport of material into the neurites depends
on kinesin (Baas et al., 1991; Feiguin et al., 1994).
Differentiated wild-type N2a cells contain abundant mi-
tochondria in their neurites, extending up to the tip (Fig.
13 d). In striking contrast, the neurites of differentiated
N2a cells transfected with tau showed very few mitochon-
dria (Fig. 13 a and Table I). The remarkable depletion of
mitochondria from neuritic extensions in these cells indi-
cates that tau overexpression in neuronal cells leads to the
same phenotype as seen in CHO cells, and again can be
explained by an impairment of plus-endÐdirected microtu-
bule-dependent transport of mitochondria. The absence of
these organelles would severely limit the energy supply of
neurites and could cause their degeneration. These obser-
vations have implications for the cellular causes of Alz-
heimerÕs disease where elevated and mislocalized tau occurs
concomitant with neuronal degeneration (as discussed
later).
Since the distribution of mitochondria was impaired in
differentiated N2a neuroblastoma cells overexpressing
tau, we asked whether the ER was affected as well (judg-
ing by immunofluorescence with an ER-specific antibody;
Louvard et al., 1982). Control cells showed ER elements
throughout the cell body mostly surrounding the nucleus,
but visible in the neuritic structures. By contrast, the ma-
jority of tau-overexpressing cells (z82%, Table I) showed
that the ER was collapsed towards the cell center, without
extending around the nucleus (Fig. 14 a). The overall in-
tensity of ER-staining remained the same in the two cell
Figure 11. The ER organiza-
tion is altered in CHO cells
overexpressing tau. Tau40-
stable (a and b) and mock-
transfected CHO cells (c
and  d) were stained with
DiOC6(3) to visualize the
ER. In tau-stable cells, the
ER is less branched and does
not reach the cell periphery,
while in control cells the ER
extends almost to the plasma
membrane and displays a
more complex structure.
Note that, although the ex-
tension of the ER of the
smaller cell in Fig. 11 b seems
to be less effected when com-
pared with the larger cells,
the branching and complex-
ity of the endoplasmic reticu-
lum is significantly reduced
when compared with mock-
transfected cells in c and d.
The cell periphery is outlined
for clarity. Bar, 10 mm.The Journal of Cell Biology, Volume 143, 1998 788
types. In particular, the ER extending into the neurites
was strongly reduced in the tau-stable cells (compare Fig.
14, a and d). Thus, an elevated level of tau in differentiated
N2a cells causes a retraction of the ER structure in the cell
body similar to the effect seen in CHO cells, leading to a
decrease of the ER in neurites, presumably by affecting
intracellular transport processes. Consistent with this,
the neurites of tau-overexpressing cells are significantly
shorter than those of control cells (e.g., the number of neu-
rites extending $30  mm decreases approximately three-
fold, Table I).
Discussion
Tau Retards Plus-EndÐdirected Transport of 
Mitochondria, ER, and Transport Vesicles Along 
Microtubules
In this study, we have investigated how an increased level
of tau protein (generated by overexpression or microinjec-
tion) affects intracellular transport in CHO and neuroblas-
toma cells. The main results can be summarized as follows:
(a) increased tau leads to a clustering of mitochondria and
peroxisomes near the MTOC (Fig. 2), to a contraction of
the intermediate filament system and the ER (Fig. 11),
and to a reduced rate of exocytosis (e.g., of transferrin re-
ceptor, Fig. 12). The cells lose their elongated shape and
become rounded (Fig. 2), and their growth rate slows
down. Mitochondria and ER are decreased in neuritic pro-
cesses (Figs. 13 and 14; Table I). (b) All of the above ef-
fects are observed at relatively low levels of tau overex-
pression where the microtubule network is not impaired
(no bundling, no detachment from MTOC); in fact, they
depend on the integrity of the microtubule network. The
effects also depend on a strong binding of tau to microtu-
bules (Kd z1 mM, provided by the repeats and proline-rich
flanking domain). (c) If the microtubule network is dis-
rupted by drugs (i.e., disassembly by nocodazole, Fig. 5),
or detachment of microtubules from MTOC and random-
ization by taxotere (Fig. 8), the tau-induced changes in the
distribution of mitochondria are reversed so that the or-
ganelles become dispersed throughout the cell again (Fig.
10). (d) Inhibition of dynein (via overexpression of dyna-
mitin) reverses the effects of tau overexpression and al-
lows the dispersion of mitochondria (Figs. 9 and 10).
These effects can be explained by the assumption that
tau interferes preferentially with the plus-endÐdirected
transport along microtubules involving kinesin, while
the  minus-end transport involving dynein is less affected.
The directionality of organelle transport observed with
the tau-transfected cells is consistent with a number
of reports showing that plus-endÐdirected transport is
achieved mainly by kinesin-like motors, and the reverse
transport by dynein (Vallee and Sheetz, 1996; Rickard and
Kreis, 1996; Hirokawa, 1998; Lippincott-Schwartz, 1998).
For example, mitochondria are transported by the kinesin
motors KIF1B (Nangaku et al., 1994) and KIF5B (Tanaka et
al., 1998), or in the opposite direction by dynein (Hirokawa et
al., 1990), and, therefore, inhibition of kinesin leads to a
net retrograde transport of mitochondria. Rodionov et al.
(1993) have shown that microinjection of an inhibitory ki-
nesin antibody, which cross-reacts with several members
of the kinesin superfamily, leads to a strikingly similar
phenotype of mitochondrial clustering. Furthermore, the
targeted disruption of mouse conventional kinesin heavy
chain KIF5B results in the perinuclear clustering of mito-
chondria (Tanaka et al., 1998). Similarly, the extension of
the ER and the intermediate filament system or the traf-
ficking of vesicles is determined by a balance between ki-
nesin- and dynein-dependent movements so that the ER
and the vimentin-network collapses when kinesin is sup-
pressed (Feiguin et al., 1994; Gyoeva and Gelfand, 1991).
(The term ÒanterogradeÓ is used for the plus-endÐdirected
axonal transport along microtubules, but also for the mi-
nus-endÐdirected transport from ER to Golgi, so that we
prefer the term Òplus-endÐdirectedÓ for the present dis-
cussion.)
The function of tau or MAPs is usually discussed in
terms of their role in microtubule stabilization (Matus,
1994), the generation of cell processes (Kosik and McCon-
logue, 1994), in their spacer function between microtu-
bules (Chen et al., 1992), or as anchoring sites for other
proteins (Obar et al., 1989; Ookata et al., 1995). The data
presented here point to a new function of tau; that is, regu-
lation of transport within cells by the variation of the intra-
cellular concentration of tau on the surface of microtu-
bules. Since related effects have been observed with
MAP4 (Bulinski et al., 1997), this may be a general func-
tion of MAPs. In this context, it is of interest to note that,
although MAP4 efficiently stabilizes microtubules in vitro
and in vivo, the mitochondrial distribution in MAP4-over-
expressing cells has been reported to not be altered
(Nguyen et al., 1997). This argues against the possibility
that a change in lifetime of microtubules accounts for the
Figure 12. Transferrin recycling is retarded by tau overexpres-
sion. Cells were seeded on cover slips and preincubated with
TMR-labeled transferrin in serum-free medium for 2 h. Excess
transferrin was removed and tau-stable and mock-transfected
cells were fixed in methanol. Residual transferrin fluorescence
was then quantitated and plotted (a). Note that, at early time
points (7 min), the transferrin fluorescence in tau-stable cells is
decreased by z10%, whereas in control cells 50% of transferrin
is exocytosed in the same time interval. 300 cells were quantitated
per time point and cell line. (b) Time course of the exocytosis of
transferrin after equilibration of tau-stable and mock-transfected
cells with fluorescently labeled transferrin. A significant decrease
of exocytosed transferrin can be seen 5Ð10 min after start of the
experiment in tau-stable compared with control cells. Fluores-
cent signals were normalized to total cell numbers in each ex-
periment. Data represent averages of four independent experi-
ments. Ebneth et al. Tau Inhibits Kinesin-dependent Vesicle Trafficking 789
effect of mitochondrial clustering, because the lifetime
would be increased both by MAP4 and tau. More impor-
tantly, the comparison perhaps points to different func-
tions of tau and MAP4 in vivo.
Inhibition of Motor Activity by MAPs
The question of whether and how MAPs and motors could
interfere with each other on a microtubule has been the
subject of extended discussions, mainly because experi-
mental evidence obtained in vitro remained ambiguous
(e.g., Paschal et al., 1989; Von Massow et al., 1989; Rodi-
onov et al., 1990; Lopez and Sheetz, 1993; Hagiwara et al.,
1994). The results depended not only on the type of MAPs
and motors used, their effective concentrations (in solu-
tion or bound to a surface), but also on the experimental
design (microtubule gliding or bead movement assay). The
majority of the in vitro results suggested that tight binding
of MAPs to microtubules via the microtubule-binding do-
main and a large projection domain was a prerequisite for
observing any inhibition in motility. Thus, MAP2 could re-
tard kinesin or dynein, while smaller MAPs (e.g., tau,
MAP2c) had a much smaller effect or none at all (Von
Massow et al., 1989; Lopez and Sheetz, 1993).
Conceptually, one can analyze the interference between
MAPs and motors in terms of competition for common
binding sites on a microtubule and/or in terms of steric
hindrance (Lopez and Sheetz, 1993). A purely competitive
mechanism would require only the microtubule-binding
domain of MAPs (repeats plus flanking regions), while
steric hindrance would depend on both microtubule bind-
ing plus the NH2-terminal projection domain. Since sev-
eral of the earlier studies had emphasized that large
projection domains of MAPs were necessary for motor in-
hibition, we were surprised to find that a small MAP such
as tau, overexpressed only moderately in cells, could be in-
hibitory for plus-endÐdirected transport. This could be
achieved even with constructs having no projection do-
Figure 13. Transport of mitochondria into neu-
rites of differentiated neuroblastoma cells is im-
paired by overexpression of tau. Tau40-stable
(aÐc) and mock-transfected N2a cells (dÐf) were
differentiated for 2 d by addition of 1 mM reti-
noic acid into medium containing 0.1% fetal
calf serum and fixed in methanol. Mitochon-
dria were visualized with MitoTrackerª Green
(a and d), immunostaining was done with anti-
bodies against tubulin (b and e) and tau (c and
f). It can be clearly seen that significantly fewer
mitochondria are present in the neurites of tau-
stable cells in contrast to control cells (compare
a and d, and Table I). In addition, mitochon-
dria in tau-stable cells appear to be more clus-
tered in the vicinity of the MTOC (a), similar to
tau-stable CHO cells. The comparable staining
intensity of the cell bodies indicates that the
clustering effect is not due to a lower number
of mitochondria in the tau-transfected cell. Bar,
10 mm.The Journal of Cell Biology, Volume 143, 1998 790
main (K35). Constructs with lower affinity generally had
no effect (K10, K12), even when the projection domain
was present, as in K23 (Fig. 3). Obviously the cellular envi-
ronment reacts more sensitively to MAPs than the experi-
mental systems used in vitro. This could be explained by
several factors: in the crowded environment of a cell, even
shorter MAPs could have noticeable effects on transport,
which would be most apparent for small motors (note that
KIF1B, responsible for mitochondrial transport, is only
35-nm long, compared with 75 nm for conventional kine-
sin; Nangaku et al., 1994; Scholey et al., 1989). Secondly,
the periods of observation are long, compared with the in
vitro experiments, so that small differences in transport
velocities can accumulate to a measurable extent. Thirdly,
the cellular effects result from an interplay between plus-
and minus-end motors, which are differently affected by
MAPs, while in vitro experiments were done with one type
of motor only. Finally, the in vitro studies are usually done
with an excess of motors that tend to overwhelm the resis-
tance that MAPs might offer. A comparison between the
different isoforms and constructs of tau shows that the in-
hibition of vesicle movement is dominated by the competi-
tion between tau and motors for binding sites on the mi-
crotubules, while steric hindrance is of lesser importance.
The direction of microtubule-based transport is thought
to be determined by particular motor proteins anchored at
the organelle by means of adaptor complexes (e.g., kinec-
tin, dynactin; Kumar et al., 1995; Burkhardt et al., 1997).
The variety of motor proteins in cells makes it possible, in
principle, for each type of vesicle or organelle to select one
or more type of motor, depending on the required destina-
tion (Hirokawa, 1998; Hamm-Alvarez et al., 1993). In spite
of attached motors, the movement of vesicles is not simply
unidirectional, but rather saltatory, with frequent detach-
ments and even reversals (Wacker et al., 1997). The net
movement is therefore the result of many trials, biased in a
particular direction. Inside a cell, MAPs could inhibit the
activity of a motor in several ways; e.g., by preventing the
initial attachment, by reducing the velocity, or by reducing
the run length. In the present context, the important point
is that tau most likely affects the balance between differ-
ent directions, impairing the plus-endÐdirected move-
ments of mitochondria more than the minus-endÐdirected
ones, and this results in the clustering of these organelles
near the MTOC, whereas the phenotype of ER retraction
or the slow down in the export of transferrin might be
achieved by simply reducing the overall transport pro-
cesses or influencing the run length of motor proteins on
microtubules.
Besides saltatory particle movement with directional
bias, one should consider other mechanisms as well. For
example, extension of the ER network can be driven by
microtubule polymerization where the tips of microtu-
bules are attached to the membrane by special attachment
complexes (Allan and Vale, 1994; Waterman-Storer et al.,
1995), and anaphase transport of chromosomes can be
driven by microtubule depolymerization (Lombillo et al.,
1995; Merdes et al., 1997). The attachment complexes can
contain motor-like proteins that, in this case, operate as
microtubule anchors rather than as independent motors.
In practice, motor- and assembly-driven mechanisms may
coexist within the cell (Rodionov and Borisy, 1997). How-
ever, in our case, the direct motor-dependent processes
appear to be the dominant ones, as shown by the dy-
namitin-induced inhibition of dynein (Figs. 9 and 10;
Burkhardt et al., 1997). Moreover, since tau stabilizes mi-
crotubules, it would be expected to enhance plus-endÐ
directed transport if this were assembly driven, rather than
inhibiting it as observed. Finally, we note that the distribu-
tion of organelles in the cytoplasm can be influenced by
two further mechanisms, diffusion and actomyosin-based
movement. The latter appears to be restricted to special-
ized regions (e.g., near the cell cortex or the axon; Morris
and Hollenbeck, 1995; Mermall et al., 1998), but a diffu-
sional component is likely to operate at all times. It ex-
plains the dispersion of clustered mitochondria upon mi-
crotubule disassembly by nocodazole, but this is not likely
to be affected by tau.
Having determined the effects of tau overexpression in
CHO cells, an obvious question was whether analogous ef-
fects would be observable in cells of neuronal origin. In
this case, the experimental approaches are more limited
because of the smaller size of the cells. For example, a re-
distribution of organelles in the cell body is difficult to ob-
serve and the level of endogenous tau is too low for many
biochemical assays. On the other hand, vesicles and or-
ganelles are easily detectable in the long neuritic processes
of differentiated cells. Thus, the neurites of control N2a
cells show staining with the markers of mitochondria and
the ER, but N2a cells overexpressing tau only at a signifi-
cantly lower level. In agreement with the previous inter-
pretation, this means that plus-endÐdirected transport, at
least in the case of mitochondria, is impaired, leading to an
accumulation of these elements in the cell body.
The effect of tau on vesicle trafficking described here
represents a new function that has attracted little attention
thus far. This was due in part to the fact that the influence
of MAPs on the activity of motor proteins were mainly in-
vestigated in vitro, showed only weak effects, visible only
at high MAP concentrations, and were apparently re-
stricted to high molecular weight MAPs (Paschal et al.,
1989; Von Massow et al., 1989; Lopez and Sheetz, 1993;
Hagiwara et al., 1994). Nevertheless, in the context of
Table I. Quantitation of the Phenotypic Effects of Tau 
Overexpression in N2a-Neuroblastoma Cells
N2a tau40 N2a mock
Neurites 5.4% 15%
(length .30 mm)
Mitochondria in neurites 17% 94%
(.6 per neurite)
ER distribution 82% 23%
(clustered)
A minimum of 150 cells were analyzed in four (neurite length and mitochondria) or
three (ER distribution) independent experiments. In differentiated, mock-transfected
cells, 15% of the cells developed neurites longer than 30 mm, whereas, in tau-stable
cells, this value drops to only 5.4%. The effect of tau-overexpression becomes even
more impressive when analyzing the mitochondria present in the neuritic structures:
only 17% of tau-stable cells transported more than six mitochondria into their neu-
rites, compared with 94% of control cells. The average number of mitochondria in the
control cells was z10Ð20 per neurite (data not shown). The ER was regarded as clus-
tered when it did not surround the nucleus of the cells. In tau-stable cells, up to 82%
displayed this phenotype. In contrast, in mock-transfected cells, only 23% of cells had
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cells, the subtle effects become magnified and visible as re-
distribution of cellular components. The most important
prerequisite for tauÕs influence on intracellular traffic is
the tight binding to microtubules due to the repeats and
the flanking domains (z1Ð2 mM) while the projection do-
main has only a minor effect. This implies that the phos-
phorylation of tau should play an important role since this
regulates tauÕs affinity to microtubules. One can broadly
distinguish two types of phosphorylation of tau, proline di-
rected (affecting Ser-Pro or Thr-Pro motifs and induced
by proline-directed kinases such as MAP kinase, GSK3,
cdk5) and nonÐproline directed (induced by second-mes-
sengerÐdependent kinases such as PKA, PKC, CaMK,
MARK; for review see Mandelkow et al., 1995). Proline-
directed phosphorylation has only a moderate influence on
tau-microtubule interactions (Biernat et al., 1993), whereas
two other sites potently disrupt the interaction, Ser262
(phosphorylated by MARK; Drewes et al., 1997) and
Ser214 (phosphorylated by PKA; Zheng-Fischhfer et al.,
1998; both these sites are enhanced in AlzheimerÕs tau).
Thus far, such sites were mainly seen as modulators of
microtubule stability. However, in the light of our present
results, one should also view the MAP-microtubule affin-
ity-regulating phosphorylation reactions as modulators of
intracellular traffic. In this scenario, tau bound to microtu-
bules would present resistance to plus-endÐdirected move-
ment, which would be relieved by tauÕs phosphorylation
and detachment from microtubules. Since the outward
flow of material is a prerequisite for cell polarity and dif-
ferentiation (Feiguin et al., 1994; Bradke and Dotti, 1997),
the activity of tau kinases would become important at this
point. It is interesting to note that vesicle transport can be
inhibited by MAP2, but relieved by a kinase that is proba-
bly related to MARK (Drewes et al., 1997; Lopez and
Sheetz, 1995), a kinase that phosphorylates MAP2c and
MAP4 in vitro (Illenberger et al., 1996), and therefore can
Figure 14. The expansion of the endoplasmic
reticulum in differentiated neuroblastoma cells is
significantly reduced by overexpression of tau.
Tau-stable N2a cells (aÐc) or mock-transfected
cells (dÐf) were induced to differentiate, and
then fixed in paraformaldehyde and triple-la-
beled with antibodies against the ER (a and d),
tubulin (b and e), and tau (c and f). In contrast to
control cells, z82% of tau-stable neuroblastoma
cells show the ER clustered at one side of the nu-
cleus (a), whereas in mock-transfected cells the
ER surrounds the entire nucleus (d; compare Ta-
ble I). Furthermore, the expansion of the ER
into the neurites in control cells (d) can clearly
be seen. In tau-stable cells, only a faint signal of
ER-immunoreactivity is visible in neuritic pro-
cesses. The total intensity of the ER stain is the
same in both cells. Arrowheads in a and d are in-
dicating the position of the neurite relative to the
cell body. Bar, 10 mm.The Journal of Cell Biology, Volume 143, 1998 792
be expected to regulate the affinity of MAPs to microtu-
bules in general. This points to another interesting obser-
vation: it has been shown that MAP1A can compensate
for the lack of tau in knock-out mice (Harada et al., 1994),
suggesting that the function of MAPs is partially redun-
dant. Whereas axonal elongation was not affected in these
animals, microtubule stability was decreased in some ax-
ons. It is conceivable that different MAPs regulate the
transport of different organelles and in different cell com-
partments. Thus, it would be interesting to correlate the
distribution of organelles and MAPs in mouse models
lacking or overexpressing MAPs to get further clues for
the functions of MAPs in intracellular transport.
Implications for Neuronal Degeneration in
AlzheimerÕs Disease
The effects of tau overexpression on mitochondrial dis-
tribution, vesicle-trafficking, and the ER have important
implications for AlzheimerÕs disease. In AD, tau is ab-
normally phosphorylated, aggregated into paired helical
filaments, and mislocalized from the axon to the somato-
dendritic compartment (Binder et al., 1985; Wischik et al.,
1988; Braak et al., 1994). In addition, it has been reported
that intracellular tau-protein concentration in AD brain is
elevated (Khatoon et al., 1992). In neurons, this mislocal-
ization and elevated intracellular concentration of tau
would affect the transport of mitochondria or ER to the
most peripheral regions of the axons and would lead to a
decrease in glucose metabolism and ATP synthesis in
these compartments, causing energy deficits, loss of Ca21
homeostasis, or lipid synthesis (Futerman and Banker,
1996; Mattson and Guo, 1997). Finally, this may lead to
degeneration of the neuron, presumably beginning from
the most distal regions, leading to the so called Òdying
backÓ of axons (Braak et al., 1994; Trojanowski and Lee,
1995). In this context, it is of special interest that compro-
mised mitochondrial function has indeed been shown to
associate with late onset AlzheimerÕs disease (Davis et al.,
1997). In addition, a slowing down of transport processes
could affect the proper distribution of proteins, particu-
larly of amyloid precursor protein (APP), another key
player in the progression of AlzheimerÕs disease that is re-
routed by transcytosis (Simons et al., 1995), and whose
proteolytic processing to the amyloidogenic peptide Ab1-42
takes place in the endoplasmic reticulum (Cook et al.,
1997; Hartmann et al., 1997). Thus, a transport inhibition
due to the overexpression and mislocalization of tau in
neurons might increase production of Ab1-42. Conversely,
overproduction of amyloidogenic variants of APP corre-
lates with an increased level of tau protein and tau mRNA
(Lee et al., 1996), and, in the AlzheimerÕs-related Down
syndrome, APP and tau are both upregulated (Oyama et al.,
1994). Finally, the mutant presenilins PS1 and PS2 that are
responsible for familial AlzheimerÕs disease have been
shown to interact with APP in the endoplasmic reticulum,
thereby enhancing the production of Ab (Xia et al., 1997).
Thus, future work might give new clues to an understand-
ing of AlzheimerÕs disease since it might experimentally
link the function of AD-specific gene products, such as
APP and the presenilins, with mitochondrial energy sup-
ply and tau protein.
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